Cresset, an innovative provider of integrated in silico solutions for drug discovery, has completed its SOC 2Type 1 audit, achieving compliance with the leading industry standards for customer data security.
Cresset’s Head of IT Iain Ronayne said: “Achieving SOC 2 Type 1 compliance is a powerful endorsement of the strength, resilience, and effectiveness of our IT infrastructure and security processes, which have been thoroughly audited and validated by independent experts.”
Cresset said it got help in achieving SOC 2 compliance from Kontain, a security advisory organization whose expertise in information security guided them through the process, from assessment to implementation of security controls.
Cresset said this support ensured it fully met the SOC 2 requirements and strengthened their overall security.
The audit was completed with the help of Johanson Group LLP, a premier certification body helping organizations to obtain and maintain global compliance standards. SOC 2 has a rigorous requirement on how companies handle customer data and information, so compliance guarantees there are established and implemented organizational practices in place to safeguard customer data, Cresset said.
Cresset’s Chief Technology Officer Dr Tim Cheeseright said: